PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 1 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $64,586,000 | +606.0% | 3,590,091 | +179.8% | 0.02% | +566.7% |
| Q1 2020 | $9,148,000 | -35.9% | 1,283,179 | +114.6% | 0.00% | -25.0% |
| Q4 2019 | $14,279,000 | -51.5% | 597,948 | -45.5% | 0.00% | -55.6% |
| Q3 2019 | $29,442,000 | +41.7% | 1,097,777 | +43.3% | 0.01% | +50.0% |
| Q2 2019 | $20,784,000 | -25.9% | 766,053 | -5.3% | 0.01% | -25.0% |
| Q1 2019 | $28,066,000 | +87.0% | 808,812 | +5.2% | 0.01% | +33.3% |
| Q4 2018 | $15,006,000 | -2.6% | 768,722 | +32.9% | 0.01% | +50.0% |
| Q3 2018 | $15,402,000 | -2.9% | 578,346 | +37.7% | 0.00% | 0.0% |
| Q2 2018 | $15,861,000 | -16.1% | 419,932 | -27.4% | 0.00% | -33.3% |
| Q1 2018 | $18,903,000 | -7.7% | 578,771 | +37.6% | 0.01% | +50.0% |
| Q4 2017 | $20,476,000 | -23.6% | 420,632 | -15.2% | 0.00% | -33.3% |
| Q3 2017 | $26,793,000 | -30.7% | 495,908 | -27.9% | 0.01% | -40.0% |
| Q2 2017 | $38,650,000 | +68.0% | 688,092 | +17.2% | 0.01% | +66.7% |
| Q1 2017 | $23,006,000 | +342.3% | 587,046 | +153.2% | 0.01% | +500.0% |
| Q4 2016 | $5,202,000 | -74.4% | 231,806 | -74.1% | 0.00% | -83.3% |
| Q3 2016 | $20,299,000 | +575.7% | 893,854 | +602.1% | 0.01% | +500.0% |
| Q2 2016 | $3,004,000 | -76.4% | 127,306 | -79.6% | 0.00% | -80.0% |
| Q1 2016 | $12,747,000 | +266.8% | 624,846 | +825.2% | 0.01% | +400.0% |
| Q4 2015 | $3,475,000 | -30.7% | 67,539 | -42.6% | 0.00% | 0.0% |
| Q3 2015 | $5,017,000 | +339.3% | 117,720 | +369.5% | 0.00% | – |
| Q2 2015 | $1,142,000 | +340.9% | 25,075 | +267.4% | 0.00% | – |
| Q1 2015 | $259,000 | -50.3% | 6,825 | -62.9% | 0.00% | – |
| Q4 2014 | $521,000 | +41.2% | 18,413 | +45.7% | 0.00% | – |
| Q2 2014 | $369,000 | -10.2% | 12,635 | -20.3% | 0.00% | – |
| Q1 2014 | $411,000 | -54.2% | 15,859 | -54.5% | 0.00% | – |
| Q4 2013 | $897,000 | -84.3% | 34,826 | -83.7% | 0.00% | -100.0% |
| Q3 2013 | $5,731,000 | +8.9% | 214,225 | -0.0% | 0.00% | 0.0% |
| Q2 2013 | $5,264,000 | – | 214,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|